Erector Spinae Plane Block as Analgesia in Patients for Colectomy
1 other identifier
interventional
60
1 country
1
Brief Summary
Management of postoperative pain relief is largely inadequate. Despite the recent advances in pain management, postoperative pain incidence has not decreased; most patients still experience severe pain after major surgery. Poorly or inadequately controlled pain was reported to be linked to prolonged hospitalization, decreased patient satisfaction, the risk of readmission, and a higher incidence of postoperative complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable colorectal-cancer
Started Aug 2021
Typical duration for not_applicable colorectal-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2024
CompletedFirst Submitted
Initial submission to the registry
April 26, 2025
CompletedFirst Posted
Study publicly available on registry
May 4, 2025
CompletedMay 13, 2025
April 1, 2025
3.3 years
April 26, 2025
May 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
morphine consumption
postoperative total morphine consumption over 24 hours
From the time of end of surgery till the pass of the first 24 hours postoperatively
Study Arms (2)
ESPB
ACTIVE COMPARATORESPB using local anaesthetic 20 ml 0.25% bupivacaine on each side
Saline
PLACEBO COMPARATORESPB using normal saline 20 ml on each side
Interventions
Eligibility Criteria
You may qualify if:
- patients of colorectal carcinoma scheduled for elective colectomy
You may not qualify if:
- Patients with a body mass index (BMI) of 35 kg/m2 or above
- patients with a history of hepatic or renal diseases
- patients with second- or third-degree heart blocks
- patients with coagulopathies
- patients with history of hypersensitivity to local anesthetics
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
faculty of medicine, Suez Canal University
Ismailia, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
April 26, 2025
First Posted
May 4, 2025
Study Start
August 1, 2021
Primary Completion
November 30, 2024
Study Completion
December 15, 2024
Last Updated
May 13, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share